Singapore markets open in 1 hour 23 minutes
  • Straits Times Index

    3,201.89
    +10.73 (+0.34%)
     
  • S&P 500

    4,088.85
    +80.84 (+2.02%)
     
  • Dow

    32,654.59
    +431.17 (+1.34%)
     
  • Nasdaq

    11,984.52
    +321.73 (+2.76%)
     
  • BTC-USD

    30,462.51
    +556.34 (+1.86%)
     
  • CMC Crypto 200

    677.94
    +435.26 (+179.36%)
     
  • FTSE 100

    7,518.35
    +53.55 (+0.72%)
     
  • Gold

    1,812.60
    -6.30 (-0.35%)
     
  • Crude Oil

    113.64
    +1.24 (+1.10%)
     
  • 10-Yr Bond

    2.9680
    +0.0910 (+3.16%)
     
  • Nikkei

    26,659.75
    +112.70 (+0.42%)
     
  • Hang Seng

    20,602.52
    +652.31 (+3.27%)
     
  • FTSE Bursa Malaysia

    1,548.60
    +4.19 (+0.27%)
     
  • Jakarta Composite Index

    6,644.47
    +46.47 (+0.70%)
     
  • PSE Index

    6,594.66
    +92.54 (+1.42%)
     

Seagen to Present at the J.P. Morgan Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

BOTHELL, Wash., December 20, 2021--(BUSINESS WIRE)--Seagen Inc. (Nasdaq: SGEN) today announced that management will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 3:00 p.m. Eastern Time. The presentation will be webcast live and available for replay from the investor section of Seagen’s website at investor.seagen.com.

About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211220005153/en/

Contacts

For Investors
Peggy Pinkston
Senior Vice President, Investor Relations
(425) 527-4160
ppinkston@seagen.com

For Media
David Caouette
Vice President, Corporate Communications
(310) 430-3476
dcaouette@seagen.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting